[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fR6UJ2FK455SxsVS-Q9BKXZc-BodvqFSG8SsHYpCXzIY":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":8,"nonDrugCount":11,"topConditions":12,"upcomingReadouts":32,"phaseBuckets":38,"rows":45},"Clinique Ovo",[4],36,false,1,3,20945,26,[13,16,19,21,24,26,28,30],{"name":14,"count":15},"Infertility",15,{"name":17,"count":18},"IVF",4,{"name":20,"count":9},"Fertility Disorders",{"name":22,"count":23},"Infertility, Male",2,{"name":25,"count":8},"Controlled Ovarian Simulation",{"name":27,"count":8},"Azoospermia",{"name":29,"count":8},"Reproductive Disorder",{"name":31,"count":8},"Polycystic Ovary Syndrome",[33],{"nctId":34,"briefTitle":35,"date":36,"intervention":37},"NCT06997900","Menopur And Rekovelle Combination Study Version 2.0","2026-08","Combination therapy : Follitropin delta and HP-hMG",[39,40,41,42,43,44],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[46,69,95,113,139,163,189,207,231,257,275,304],{"intervention":37,"totalTrials":8,"cells":47},{"EARLY_PHASE1":48,"PHASE1":51,"PHASE2":53,"PHASE3":63,"PHASE4":65,"NA":67},{"trials":49,"activeCount":50},[],0,{"trials":52,"activeCount":50},[],{"trials":54,"activeCount":8,"soonestReadout":36},[55],{"nctId":34,"briefTitle":35,"status":56,"phases":57,"primaryCompletion":36,"completion":58,"start":59,"enrollment":60,"conditions":61,"interventions":62},"RECRUITING",[41],"2027-08","2025-07-04",200,[17,25,20],[37],{"trials":64,"activeCount":50},[],{"trials":66,"activeCount":50},[],{"trials":68,"activeCount":50},[],{"intervention":70,"totalTrials":8,"cells":71},"Contraceptives,",{"EARLY_PHASE1":72,"PHASE1":74,"PHASE2":76,"PHASE3":78,"PHASE4":80,"NA":93},{"trials":73,"activeCount":50},[],{"trials":75,"activeCount":50},[],{"trials":77,"activeCount":50},[],{"trials":79,"activeCount":50},[],{"trials":81,"activeCount":50},[82],{"nctId":83,"briefTitle":84,"status":85,"phases":86,"primaryCompletion":87,"completion":87,"start":88,"enrollment":89,"conditions":90,"interventions":91},"NCT01638767","NuvaRing Versus Marvelon in the Coordination of In Vitro Fertilization Cycles","TERMINATED",[43],"2014-07","2012-07",7,[14],[70,92],"Contraceptive, Vaginal ring",{"trials":94,"activeCount":50},[],{"intervention":92,"totalTrials":8,"cells":96},{"EARLY_PHASE1":97,"PHASE1":99,"PHASE2":101,"PHASE3":103,"PHASE4":105,"NA":111},{"trials":98,"activeCount":50},[],{"trials":100,"activeCount":50},[],{"trials":102,"activeCount":50},[],{"trials":104,"activeCount":50},[],{"trials":106,"activeCount":50},[107],{"nctId":83,"briefTitle":84,"status":85,"phases":108,"primaryCompletion":87,"completion":87,"start":88,"enrollment":89,"conditions":109,"interventions":110},[43],[14],[70,92],{"trials":112,"activeCount":50},[],{"intervention":114,"totalTrials":8,"cells":115},"Adjuvant Growth Hormon",{"EARLY_PHASE1":116,"PHASE1":118,"PHASE2":120,"PHASE3":122,"PHASE4":124,"NA":137},{"trials":117,"activeCount":50},[],{"trials":119,"activeCount":50},[],{"trials":121,"activeCount":50},[],{"trials":123,"activeCount":50},[],{"trials":125,"activeCount":50},[126],{"nctId":127,"briefTitle":128,"status":129,"phases":130,"primaryCompletion":131,"completion":132,"start":133,"enrollment":134,"conditions":135,"interventions":136},"NCT01715324","Adjuvant Growth Therapy in in Vitro Fertilization","COMPLETED",[43],"2021-07","2021-08","2014-06-25",288,[14],[114],{"trials":138,"activeCount":50},[],{"intervention":140,"totalTrials":8,"cells":141},"Glucagon",{"EARLY_PHASE1":142,"PHASE1":144,"PHASE2":146,"PHASE3":148,"PHASE4":150,"NA":161},{"trials":143,"activeCount":50},[],{"trials":145,"activeCount":50},[],{"trials":147,"activeCount":50},[],{"trials":149,"activeCount":50},[],{"trials":151,"activeCount":50},[152],{"nctId":153,"briefTitle":154,"status":155,"phases":156,"primaryCompletion":157,"completion":157,"start":157,"enrollment":50,"conditions":158,"interventions":160},"NCT01674283","Effect of Glucagon on Uterine Contractility at the Time of Embryo Transfer in in Vitro Fertilization","WITHDRAWN",[43],"2013-10",[159],"Women With Fertility Disorder",[140],{"trials":162,"activeCount":50},[],{"intervention":164,"totalTrials":8,"cells":165},"Metformin",{"EARLY_PHASE1":166,"PHASE1":168,"PHASE2":170,"PHASE3":172,"PHASE4":185,"NA":187},{"trials":167,"activeCount":50},[],{"trials":169,"activeCount":50},[],{"trials":171,"activeCount":50},[],{"trials":173,"activeCount":50},[174],{"nctId":175,"briefTitle":176,"status":155,"phases":177,"primaryCompletion":178,"completion":179,"start":180,"enrollment":50,"conditions":181,"interventions":183},"NCT01638988","Clomifene Citrate Versus Metformin in First-line Treatment of Infertility in Patients With Polycystic Ovary Syndrome and a Resistance to Insulin",[42],"2013-11","2015-12","2013-09",[31,182],"Insulin Resistance",[164,184],"Clomiphene citrate",{"trials":186,"activeCount":50},[],{"trials":188,"activeCount":50},[],{"intervention":184,"totalTrials":8,"cells":190},{"EARLY_PHASE1":191,"PHASE1":193,"PHASE2":195,"PHASE3":197,"PHASE4":203,"NA":205},{"trials":192,"activeCount":50},[],{"trials":194,"activeCount":50},[],{"trials":196,"activeCount":50},[],{"trials":198,"activeCount":50},[199],{"nctId":175,"briefTitle":176,"status":155,"phases":200,"primaryCompletion":178,"completion":179,"start":180,"enrollment":50,"conditions":201,"interventions":202},[42],[31,182],[164,184],{"trials":204,"activeCount":50},[],{"trials":206,"activeCount":50},[],{"intervention":208,"totalTrials":8,"cells":209},"Filgrastim",{"EARLY_PHASE1":210,"PHASE1":212,"PHASE2":214,"PHASE3":216,"PHASE4":227,"NA":229},{"trials":211,"activeCount":50},[],{"trials":213,"activeCount":50},[],{"trials":215,"activeCount":50},[],{"trials":217,"activeCount":50},[218],{"nctId":219,"briefTitle":220,"status":85,"phases":221,"primaryCompletion":222,"completion":222,"start":223,"enrollment":15,"conditions":224,"interventions":226},"NCT02149277","Gcsf Injection in Women With Repeated Implantaiton Failure",[42],"2017-12","2013-03",[225],"Repeated Embryo Implantation Failure",[208],{"trials":228,"activeCount":50},[],{"trials":230,"activeCount":50},[],{"intervention":232,"totalTrials":8,"cells":233},"menotropins for",{"EARLY_PHASE1":234,"PHASE1":236,"PHASE2":238,"PHASE3":240,"PHASE4":253,"NA":255},{"trials":235,"activeCount":50},[],{"trials":237,"activeCount":50},[],{"trials":239,"activeCount":50},[],{"trials":241,"activeCount":50},[242],{"nctId":243,"briefTitle":244,"status":129,"phases":245,"primaryCompletion":157,"completion":246,"start":247,"enrollment":248,"conditions":249,"interventions":251},"NCT00971152","Effect of a Higher Than Maximum 450IU Gonadotropin Dose in an In-vitro Fertilization Cycle",[42],"2014-02","2009-09",366,[250],"Subfertility",[232,252],"urofollitropin for",{"trials":254,"activeCount":50},[],{"trials":256,"activeCount":50},[],{"intervention":252,"totalTrials":8,"cells":258},{"EARLY_PHASE1":259,"PHASE1":261,"PHASE2":263,"PHASE3":265,"PHASE4":271,"NA":273},{"trials":260,"activeCount":50},[],{"trials":262,"activeCount":50},[],{"trials":264,"activeCount":50},[],{"trials":266,"activeCount":50},[267],{"nctId":243,"briefTitle":244,"status":129,"phases":268,"primaryCompletion":157,"completion":246,"start":247,"enrollment":248,"conditions":269,"interventions":270},[42],[250],[232,252],{"trials":272,"activeCount":50},[],{"trials":274,"activeCount":50},[],{"intervention":276,"totalTrials":8,"cells":277},"Progesterone Effervescent Vaginal",{"EARLY_PHASE1":278,"PHASE1":280,"PHASE2":282,"PHASE3":298,"PHASE4":300,"NA":302},{"trials":279,"activeCount":50},[],{"trials":281,"activeCount":50},[],{"trials":283,"activeCount":50},[284],{"nctId":285,"briefTitle":286,"status":287,"phases":288,"primaryCompletion":289,"completion":290,"start":291,"enrollment":292,"conditions":293,"interventions":297},"NCT05555121","Rescue Progesterone Supplementation During Frozen Embryo Transfer","SUSPENDED",[41],"2028-04-30","2028-06-30","2022-12-01",150,[294,295,296],"Fertility Issues","Embryo Implantation","Frozen Embryo Transfer",[276],{"trials":299,"activeCount":50},[],{"trials":301,"activeCount":50},[],{"trials":303,"activeCount":50},[],{"intervention":305,"totalTrials":23,"cells":306},"Follitropin delta",{"EARLY_PHASE1":307,"PHASE1":309,"PHASE2":311,"PHASE3":325,"PHASE4":327,"NA":329},{"trials":308,"activeCount":50},[],{"trials":310,"activeCount":50},[],{"trials":312,"activeCount":50},[313],{"nctId":314,"briefTitle":315,"status":129,"phases":316,"primaryCompletion":317,"completion":318,"start":319,"enrollment":320,"conditions":321,"interventions":324},"NCT03830723","Personalized Insemination Treatment Study",[41],"2021-01-20","2021-09-27","2020-01-09",110,[14,322,323],"Intrauterine Insemination","Reproduction",[305],{"trials":326,"activeCount":50},[],{"trials":328,"activeCount":50},[],{"trials":330,"activeCount":50},[331],{"nctId":332,"briefTitle":333,"status":129,"phases":334,"primaryCompletion":335,"completion":336,"start":337,"enrollment":338,"conditions":339,"interventions":340},"NCT05873725","Retrospective Study of High Dose Follitropin Delta in a Mixed Protocol With Human Chorionic Gonadotropin",[],"2023-09-30","2024-03-19","2023-05-20",118,[17,14],[305]]